Knee OA injection study halted early
NCT ID NCT03706521
First seen Mar 21, 2026 · Last updated May 09, 2026 · Updated 9 times
Summary
This study tested an injection called lorecivivint for people with moderate to severe knee osteoarthritis. The goal was to see if it could improve cartilage health in the knee, measured by MRI scans. Only 13 people took part before the study was stopped early. The treatment aims to control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.